The France Rare Disease Clinical Trials Market size is predicted to Grow from USD 472.78 Million in 2023 to USD 1372.78 Million by 2033 at a CAGR of 11.25% during the forecast period. The market growth is driven by strong government support and growing awareness among the locals about rare disease and healthy welfare resource.